ORBIMED ADVISORS LLC 13D and 13G filings for NeuroPace, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 6:30 pm Sale |
2024-09-30 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 3,406,335 11.700% |
-597,632 (-14.93%) |
Filing |
| 2024-02-14 7:00 pm Sale |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,003,967 15.200% |
-8,314 (-0.21%) |
Filing |
| 2023-02-14 4:48 pm Unchanged |
2022-12-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,012,281 16.100% |
0 (Unchanged) |
Filing |
| 2022-02-11 4:35 pm Unchanged |
2021-12-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,012,281 16.500% |
0 (Unchanged) |
Filing |
| 2021-04-29 5:17 pm Purchase |
2021-04-26 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 4,012,281 16.800% |
4,012,281 (New Position) |
Filing |